941 related articles for article (PubMed ID: 26090067)
1. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
Dogbe EE; Arthur F
Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
[TBL] [Abstract][Full Text] [Related]
2. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
[TBL] [Abstract][Full Text] [Related]
3. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.
Acar A; Kemahli S; Altunay H; Kosan E; Oncul O; Gorenek L; Cavuslu S
Transfus Med; 2010 Jun; 20(3):152-9. PubMed ID: 20059750
[TBL] [Abstract][Full Text] [Related]
4. 'Noise' in microbiological screening assays.
Dow BC
Transfus Med; 2000 Jun; 10(2):97-106. PubMed ID: 10849378
[No Abstract] [Full Text] [Related]
5. Screening for viral markers in volunteer and replacement blood donors in West Africa.
Sarkodie F; Adarkwa M; Adu-Sarkodie Y; Candotti D; Acheampong JW; Allain JP
Vox Sang; 2001 Apr; 80(3):142-7. PubMed ID: 11840974
[TBL] [Abstract][Full Text] [Related]
6. [Detection of the nucleic acids of hepatitis B and C viruses and human immunodeficiency virus for the biological screening of blood donations. Viral Hepatitis and Retrovirus Working Groups and Subgroup for Molecular Biology Applied to Transfusion Virology of the French Blood Transfusion Society].
Laperche S
Transfus Clin Biol; 1998 Apr; 5(2):139-46. PubMed ID: 9618839
[TBL] [Abstract][Full Text] [Related]
7. Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers.
Malm K; Kragsbjerg E; Andersson S
Transfus Med; 2015 Apr; 25(2):101-5. PubMed ID: 25779614
[TBL] [Abstract][Full Text] [Related]
8. Performance and diagnostic usefulness of commercially available enzyme linked immunosorbent assay and rapid kits for detection of HIV, HBV and HCV in India.
Maity S; Nandi S; Biswas S; Sadhukhan SK; Saha MK
Virol J; 2012 Nov; 9():290. PubMed ID: 23181517
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors.
Flichman DM; Blejer JL; Livellara BI; Re VE; Bartoli S; Bustos JA; Ansola CP; Hidalgo S; Cerda ME; Levin AE; Huenul A; Riboldi V; Treviño EM; Salamone HJ; Nuñez FA; Fernández RJ; Reybaud JF; Campos RH
BMC Infect Dis; 2014 Apr; 14():218. PubMed ID: 24755089
[TBL] [Abstract][Full Text] [Related]
10. Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.
Sommese L; Sabia C; Paolillo R; Parente D; Capuano M; Iannone C; Cavalca F; Schiano C; Vasco M; De Pascale MR; Casamassimi A; Napoli C
Scand J Infect Dis; 2014 Sep; 46(9):660-4. PubMed ID: 25073538
[TBL] [Abstract][Full Text] [Related]
11. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
12. Head-to-head comparison of Enzyme Linked Immunosorbent Assay (ELISA) and Enhanced Chemiluminescence Immunoassay (ECLIA) for the detection of Transfusion Transmitted Disease (TTD) Markers; HIV, HCV and HBV in blood donors, in India.
Tiwari AK; Upadhyay AP; Arora D; Wadhwa T; Aggarwal G; Pabbi S; Luthra AS; Rawat SS
J Virol Methods; 2020 Nov; 285():113962. PubMed ID: 32860798
[TBL] [Abstract][Full Text] [Related]
13. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
Japanese Red Cross NAT Screening Research Group
Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016.
Cao WW; Zhou RR; Ou X; Shi LX; Xiao CQ; Chen TY; Tan H; Fan XG; Li BJ; Li N
BMC Infect Dis; 2018 Apr; 18(1):145. PubMed ID: 29606088
[TBL] [Abstract][Full Text] [Related]
15. Blood donors' positivity for transfusion-transmissible infections: the Serbian Military Medical Academy experience.
Vučetić D; Kecman G; Ilić V; Balint B
Blood Transfus; 2015 Oct; 13(4):569-75. PubMed ID: 26057495
[TBL] [Abstract][Full Text] [Related]
16. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.
Mine H; Emura H; Miyamoto M; Tomono T; Minegishi K; Murokawa H; Yamanaka R; Yoshikawa A; Nishioka K;
J Virol Methods; 2003 Sep; 112(1-2):145-51. PubMed ID: 12951223
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
[TBL] [Abstract][Full Text] [Related]
18. A prospective time-course study on serological testing for human immunodeficiency virus, hepatitis B virus and hepatitis C virus with blood samples taken up to 48 h after death.
Edler C; Wulff B; Schröder AS; Wilkemeyer I; Polywka S; Meyer T; Kalus U; Pruss A
J Med Microbiol; 2011 Jul; 60(Pt 7):920-926. PubMed ID: 21436373
[TBL] [Abstract][Full Text] [Related]
19. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
[TBL] [Abstract][Full Text] [Related]
20. Major risk of blood transfusion in hemolytic anemia patients.
Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
